Connect with us

Nardil (phenelzine)


Phenelzine (or NARDIL®) is mainly prescribed to treat treatment-resistant major depressive disorder, dysthymia, bipolar depression, panic disorder, social anxiety disorder, bulimia nervosa, and post-traumatic stress disorder.

Status: ACTIVE

Class: Monoamine Oxidase Inhibitor (MAOI)

FDA Approval: 1961

Dosage Forms: 15 mg

Biological Half-life: 11.6 hours

Side Effects: Dizziness, drowsiness, tiredness, weakness, insomnia, constipation, upset stomach, dry mouth, decreased urination, erectile dysfunction, increased suicide risk

Routes of Administration: Oral

Pregnancy Category: C (US)

  www.fda.gov

Like Us

Advertisement
Advertisement